HUGE.CN - FSD Pharma Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue2018-12-312017-12-312016-12-31
Total Revenue88.76325.943-
Cost of Revenue401.897--
Gross Profit-313.13425.943-
Operating Expenses
Research Development---
Selling General and Administrative10,221.699559.858176.916
Non Recurring---
Others---
Total Operating Expenses17,247.1963,550.458176.916
Operating Income or Loss-17,158.433-3,524.515-176.916
Income from Continuing Operations
Total Other Income/Expenses Net-5,552.191--
Earnings Before Interest and Taxes-17,158.433-3,524.515-176.916
Interest Expense---
Income Before Tax-22,710.624-3,524.515-176.916
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-22,710.624-3,524.515-176.916
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-22,710.624-3,524.515-176.916
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-22,710.624-3,524.515-176.916